The [d-Lys6(MJ55*)]–GnRH-I conjugate resulted in a potent effect on EBC-1 NSCLC cells, but also revealed the drawback of the ester bond, as the early-released MJ55* reduced the selectivity of the GnRHR targeting. The gene discussed is GNRHR; the disease is non-small cell lung carcinoma.